Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.428.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.482NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.335NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.36.36NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.499.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.38NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.116NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.134NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.393NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.381NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
C.32NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AE.8NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.516NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.526NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.279NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BN.1.3.7NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.25NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.9NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.7.4.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BN.1.3.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BL.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.2.47NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
ED.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BN.1.2.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CQ.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CH.1.1.24NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.2.43NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.2.19NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.38.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.7.19.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BQ.1.1.43NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.2.12NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.7.23NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.214NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.284NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.351.3 (Beta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.318NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
R.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.29 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
ML.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.283NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BE.12NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.96NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
L.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.290NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.341NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.161NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AY.69 (Delta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.46NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used